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Introduction: Worldwide prevalence of Multiple Sclerosis (MS) is growing, 
and given the huge burden on the patient, the community and the healthcare 
system, prevention interventions and symptom management in order to 
improving the quality of life of these patients are of utmost importance. One of 
the most important strategies in this regard is providing the existence of an MS 
population-based registry. Accordingly, this research was aimed at providing a 
population-based MS registry model. 
Materials and Methods: This is a qualitative study, carried out within the 
years 2016 and 2017. The population of the present study consisted of models 
of multiple sclerosis population registries. In this study, a model was provided 
using library resources, informational networks and information retrieval from 
databases of PubMed, Google Scholar, Springer, Science direct, and Wiley and 
also through studying the registry of developed countries. Then, this model 
using Delphi technique and questionnaire tool was validated and after data 
analysis, the final model was presented. 
Results: In the present study, a demographic MS registry model including the 
following eight main criteria was proposed: registry goals, data sources, 
minimum data set, data set, data processing, various types of reports, quality 
control measures and patient follow-up procedures. 
 Conclusion: Considering the prevalence of MS in Iran and the need for 
optimal data management, it is recommended that measures be taken to 
establish and use a national MS population-based registry and be one of the 
priorities of the Ministry of Health and Medical Education. 
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     Multiple Sclerosis (MS) is a highly 
chronic debilitating illness, with social and 
economic consequences, in which the 
immune system destructs the protective 
sheath around nerve fibers (myelin) and the 
destroyed myelin disrupts the connection 
between the brain and the spinal cord and 
other parts of the body ]1,2[. Some of the 
symptoms are common like muscle 
soreness, balance problems and dizziness, 
visual problems, loss of strength, dryness 
and spasms, anxiety, depression, speech 
disorders, and urinary incontinence  [3 [. 
The onset of MS is common during 
precocious puberty and between the ages of 
20 and 40 [4]; therefore, it is considered as 
one of the main causes of disability in 
young people [5]. Its prevalence among 
women is almost two times more than 
among men [6]. The main cause of this 
disease is unknown. The focus of the 
Archive of Advances in Biosciences 2019:10(2)                                                                  doi.org/10.22037/aab.v10i2.24404                                                 
 
  
 Population-Based, Emami H et al.          
 Archive of Advances in Biosciences is an open access article under the terms of the Creative Commons Attribution -NonCommercial 4.0 International License,  
81 
 
current treatments is more on reducing and 
managing attacks [7]. According to the 
Iranian MS Society (IMSS), which is a 
member of the MS International Federation, 
there are about 40,000 MS patients in Iran, 
of which only 17,000 are recorded in IMSS 
]8 [. It is critical to manage and prevent MS 
due to the fact that there is no cure for it and 
also its adverse effects on patients’ personal 
and social life: MS affects the quality of life 
in terms of physical disabilities, movement 
disorders, and mental and psychological 
effects]9]. Information Technology has a 
key role in health systems, especially in 
disease prevention, health level monitoring 
in a population, treatment and etc. [10]. One 
of the first steps for developing an effective 
disease management and prevention 
program is providing a disease registry, 
designed in two types of hospital-based 
registries and population-based registries 
[11, 12]. Population registry is an organized 
process for collecting, storing, retrieving, 
and using information from patients who 
have a particular disease and live in a 
specific geographical area ]13, 14[. One of 
the benefits of an MS Population-based 
registry is monitoring the outbreak and 
prevalence of the disease, improving the 
quality of care, and evaluating the 
effectiveness of the patients ]15,  10, 16, 17, 
18[. The National Cancer Institute and 
Abdelhac study mentioned that a registry 
system, regardless of its type, includes: 
finding cases, collecting and storing 
information, abstracting, quality control, 
follow-up with patient, and reporting ] 19, 
20[. 
In a study by Myhr, entitled "the Norwegian 
MS Registry and Biobank", it is stated that 
an MS registry contains three different 
forms: a general form for demographic data 
and two other forms for initiating treatment 
and follow-up. Recording and following-up 
with patients in this registry should be done 
at least once a year. It also points out that 
data analysis is done using descriptive 
statistics such as proportion and rate, and 
the purpose of creating such a registry, as a 
user-friendly tool, is to record all relevant 
variables ]21]. Henriksen in his study "The 
use of epidemiological multiple sclerosis 
registers in research: the Danish MS 
Registry", referred to an MS population-
based registry as an effective tool for 
epidemiological studies, neurological 
centers, general practitioners, rehabilitation 
department in hospitals, and MS 
associations as data sources, demographic 
data (age, sex, race, etc.) and clinical data 
(diagnosis, status of injury and patients 
disability, etc.) as minimum data set. In this 
study, the diagnostic criteria of the 
MacDoland mentioned as one of the 
methods for controlling the data quality 
entered in the registry, and also how to 
follow-up patients via address or telephone 
number every 6 months]16]. In a study by 
Nickerson, entitled "The multiple sclerosis 
relapse experience: patient-reported 
outcomes from the North American 
Research Committee on Multiple Sclerosis 
(NARCOMS) Registry", it pointed out that 
the purpose of an MS Registry is to research 
about MS, treat and educate patients. Using 
the registry data including demographic 
data (age, sex, race, etc.) and clinical data 
(age of onset of symptoms, age of 
diagnosis, relapse date, disability level, etc.) 
can be used for the effectiveness of 
medications. It is also stated that patients 
every six months, would fill out the 
questionnaires of the registry through the 
website of this registry, online or by mail 
]22]. 
Therefore, due to the negative consequences 
of MS prevalence and the importance of 
registries in managing and controlling the 
disease, and the fact that there is no MS 
population-based registry in Iran, this study 
was aimed to provide a population-based 
MS registry model for Iran. 
 
2. Materials and Methods 
     This is a qualitative study that was 
carried out during the years 2016 and 2017. 
The population of the study consisted of MS 
population-based registries. In this study, 
sampling was not performed. Developing 
and validation of the MS population registry 
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model, using Delphi technique was 
performed in three steps. In the first step, 
the MS population registry coordinates from 
the sources and related articles in the 
databases of PubMed, Google Scholar, 
Springer, Science Direct, and Wiley and 
also the US registry study, France, 
Denmark, and Norway extracted. 
The basic model was designed based on 
eight main criteria including registry goals, 
data sources, minimum data set (MDS), 
data set, various types of data processing, 
various types of reports, data quality control 
measures, and patient follow-up procedures. 
In the next step, to validate the model, a 
questionnaire containing 21 questions was 
developed. The questionnaire was validated 
through content validation based on the 
study of valid texts and receiving experts’ 
opinions regarding the subject of the 
research. 
The reliability of the questionnaire was 
obtained through Test-Retest and 
correlation coefficient of 92%. Then, the 
questionnaire was distributed among 5 
neurologists, 5 epidemiologists, and 5 
health and medical information 
management specialists, who were faculty 
members of medical universities with at 
least five years’ work experience, and the 
final model was presented based on the 
agreement coefficient of 85%, so that each 
criterion, with an agreement of over 85%, 
remained in the model, and other criteria, 
which were less than 85%, were eliminated 
from the model. Finally, after data analysis, 
the final model of multiple sclerosis 
population registry was presented for Iran. 
 
3. Results 
     According to the findings of the present 
research, the proposed model of MS 
population-based registry consists of 8 main 
criteria, agreed upon by experts. These 
criteria include: registry goals, data sources, 
minimum data set defined by the Center for 
Disease Control and Prevention in Ministry 
of Health and Medical Education (Iran), the 
data set used by health centers at the 
regional, municipal, provincial and national 
levels, data processing at regional, 
municipal, and provincial levels, various 
types of reports provided at regional, 
municipal, provincial and national levels, 
data quality control measures, and patient 
follow-up procedures. 
Each criterion has several sub-criteria 
among which the income level sub-criterion 
was eliminated from the final model, as 
only 60% of the experts and specialists 
agreed with it. Correspondingly, due to the 
experts’ opinion poll and the importance of 
the clinical data in this registry, more than 
90% of the experts suggested that the 
"paraclinical evaluations" sub-criteria 
should be added to the "clinical data" from 
the minimum data set criteria; this 
suggestion was applied in the final model. 
Eventually, the final model including the 8 
main criteria with several sub-criteria was 
confirmed, as shown in Table 1. 
 
Table 1. The proposed MS population-based registry model for Iran 
Criterion Sub-criterion 
MS registry goals  Treating and educating MS patients 
 Medical research 
 
Data sources of MS registry  Hospital-based registry 
 Research centers 
 Neurological centers 
 Specialists in MS neurology 
 General practitioners 
 Rehabilitation department in hospitals 
 MS association 
 Neurology clinics 
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Minimum data set defined 
by the Center for Disease 
Control and Prevention in 
Ministry of Health and 
Medical Education (Iran) 
Demographic 
Data 
 Full Name 
 Birthdate 





 Employment status 
 Level of Education 
 Marital status 
 Health insurance status 
Clinical Data  Age of onset of symptoms 
 Age of diagnosis 
 Relapse date 
 Current status of the immune system 
 Symptoms and immunological treatment 
 Use of healthcare services 
 Disability level 
the data set used 
 by health centers  
at the regional, municipal, 







 Identification number  
 Full Name 
 Gender 
 Date and place of birth 
 Personal physician / family doctor / neurologist's address and 
contact information 
 Date of death 
 Name and number of the insurance 
 Date of the last informed consent 




 Place of living (current and previous) 
 Marital status 
 Spouse's information 
 Adopted child 
 Twin 
 Gravida 
  Level of Education 
 Patient's children (count, gender and date of birth) 
 Job Status 
 Job Type 
 Insurance status 
 Membership in the MS Association 
 Quality of life (physical functioning status, mental status, general 
health status( 
 Major events of life (divorce, death of loved ones, job loss 
Clinical data 
 
 Family history and medical records of the patient 
 MS steps 
 Assessments and tests (vital signs, clinical evaluations, daily 
activities, nerve disorders, performance measurements 
 Diagnostic tests and procedures (laboratory tests and bioassays / 
biological markers, medical imaging, non-imaging diagnostics, 
treatment and intervention data, disease-modifying treatments, 
relapse treatment, MS symptom therapy, other treatments 
Data processing at regional, 
municipal, provincial levels, 
 The period between the age of first symptoms and the time of diagnosis 
 The frequency percentage of different ages showing the first symptoms 
 The frequency percentage of treatment types according to patients’ profiles 
  The frequency percentage of different diagnostic methods 
 The frequency  percentage of suicide in MS patients 
 The average age of the patients 
 The average age of diagnosis 
 The proportion of female patients in comparison to male patients  
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 Evaluation of correlation and the correlation between registry variables using 
correlation coefficient 
Various types of reports 
provided at regional, 
municipal, provincial and 
national levels 
 Report of patient follow-up information 
 Comprehensive report of all registry data based on specific diagnostic or therapeutic 
features 
 Report of medical analysis for physicians  
 Report of any registry to its higher level registry 
 Monthly reports to the physicians (such as the case report of each registry patient, 
where a case report is a detailed report of the symptoms, signs, diagnosis, treatment, 
and follow-up of an individual patient.) 
 Periodic reports for doctors to inform them from the registry status 
Data quality control 
measures 





 Completeness of information in terms of quality: relevance, 
consistency, format of information display, timeliness, coverage, 




 Assign a national identification number to each patient to prevent 
duplicate registration 
 Control the data accuracy using McDonald's criteria and 
confirmation by registry physicians 
 Re-control the final report before each data analysis and before 
printing 
Patient follow-up 





 Making a phone call or send a text message 
 Emailing 










     One of the most important measures for 
managing chronic diseases, including MS, 
is the registry design ]23]. The MS 
population-based registry is an organized 
process for collecting, storing, analyzing, 
and disseminating information about MS 
patients ]24]. The main purpose of this 
registry is to manage and control the 
symptoms of a large population of MS 
patients, its effective role in the quality of 
healthcare, engage patients in self-care and 
be used as the basis for research ]16, 17, 
18]. Accordingly, the main goals of the 
registry in the proposed model include the 
treatment and education of MS patients and 
medical research. 
Regarding the data sources of a registry, 
Rockville holds the idea of existence of two 
types of primary data and secondary data. 
Primary data is collected for direct purposes 
of the registry, and secondary data includes 
information collected in order to achieve 
other registry goals ]25[. Studies have 
shown that the most important demographic 
registry data sources include hospital 
registries, MS communities, research 
centers, neurological centers, physicians 
specializing in MS neurology, general 
practitioners, the rehabilitation department 
in hospitals, MS associations, and brain and 
neuroscience departments ]16, 26]. On the 
other hand, the collected data by the registry 
must be trustable, compatible with data 
standards, and must be proportional to the 
burden of centers’ responsibility for the 
registry ]19[. 
Considering these cases, the minimum data 
set for the proposed model includes: 2 
groups of demographic and clinical data and 
sub criteria for each group where data sets 
are at the regional, municipal, provincial, 
and national levels; 3 groups of 
administrative, socioeconomic data, and 
clinical data that provide collecting and 
storing all patient data, including 
demographic, treatment, follow-up, and 
patient history and records. This category 
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has the most compliance with the registry 
goals.  
Given that MS registry system is a 
dedicated system, it is important to cover 
the specific purposes of this system. In the 
proposed model, the data integrity is 
considered in such way that it is not so little 
that too many numbers of data elements in 
each category cause confusion and it is not 
so much that the data elements of one 
category overlap with the data elements of 
other categories. In the registry data 
management, using data processing 
techniques, it is possible to evaluate care 
patterns, assess clinical implications and 
ensure the cost effectiveness of healthcare  
]27]. 
Data processing in the registry includes 
statistical, descriptive, and analytical studies 
]28]. The most important ones of these 
processes are: the period between the age of 
the first symptoms and time of diagnosis, 
the frequency percentage of different ages 
showing the first symptoms, the frequency 
percentage of treatment types, the frequency 
percentage of suicide in MS patients, the 
average age of the patients, the average age 
of diagnosis, the proportion of female 
patients in comparison to male patients, 
validation of correlation and the correlation 
between registry variables using correlation 
coefficient ]28[. 
The aforementioned processes were 
considered in the proposed model. 
Providing information of the processed 
patient data, therapeutic analysis, providing 
monthly and periodic reports, and follow-up 
information to physicians, care providers 
and health authorities is essential which is 
considered in the proposed registry. These 
reports are initiated from the regional level 
and then referred to national levels. 
In order to have quality control and quality 
assurance in terms of completion of data 
items, visual inspection to control some 
inconsistencies such as age and birth date, 
systematic methodologies, and coding 
investigation for coding errors and 
inconsistencies were performed ]29]. 
Assessment methods for information quality 
criteria in most European advanced 
registries was the basis for the McDonald's 
diagnostic criteria ] 30, 24[. 
The registry goals without the assurance of 
the quality of the registry data could not be 
achieved. Therefore, in the current study, 
data quality control including indicators and 
other methods were considered as a major 
criterion in the design of the demographic 
multiple sclerosis registry. Communication 
methods with patients in a registry should 
be identified: a direct link (current address, 
telephone number) or through the spouse, 
guardian (young children), relative or a 
friend  ]31]. 
Since the demographic registry system 
should cover as much MS patients as 
possible, the proposed model is designed to 
follow-up patients regarding their address 
and culture type. For example, following-up 
for patients who have not access to the 
Internet must be done by sending a letter. In 
a study which was done in the United States 
in 2016, it is mentioned that follow-up with 
patients was done through the website or by 
sending a letter every six months. 
Due to the role and importance of the 
multiple sclerosis population registry in 
managing and controlling MS and reducing 
its cost, the proposed model is designed to 
cover all of the goals of a MS population 
registry. Also, a clear and precise division 
into criteria and sub-criteria of this model 
has been made. 
Time limitation of experts was one of the 
most important limitation of the study. The 
authors allocated more time to performing 
this part of study, and had two weeks for 




     Regarding the aims of the MS 
population-based registry model, namely 
improving the quality of healthcare and 
knowledge in the field of MS, monitoring 
the incidence and prevalence of the disease, 
mortality rate, geographical distribution and 
monitoring the quality of treatment, it is 
recommended that measures be taken to 
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establish and use a national MS population-
based registry in Iran, which should become 
one of the priorities of the Ministry of 
Health and Medical Education. The 
research findings could be used for these 
cases: Raising the health policymakers and 
planners’ awareness of the importance of 
the MS population-based registry, obtaining 
useful MS information for research centers, 
and using an efficient registry to manage 
patients’ data.  It is suggested that in future 
studies, software design models be 
considered based on the current study. 
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